Sam Brusco, Associate Editor06.12.23
Resonetics, a medical contract design and manufacturing firm, has named Todd Trapp as its new chief financial officer (CFO).
"We are thrilled to welcome Todd as Resonetics' next CFO," Kevin D. Kelly, president and CEO of Resonetics told the press. "His deep expertise in financial management, track record in building teams, and experience in the medical device industry make him an ideal fit for our organization. Todd will continue to elevate our financial operations and build scalable processes that enable our continued growth."
Before Resonetics, Trapp was executive VP and CFO for cardiovascular medtech company Abiomed. Prior to Abiomed, he was CFO of Watts Water Technologies. He also spent 23 years in senior financial and operational leadership roles at Honeywell.
"I am honored to join the Resonetics team as CFO," said Trapp. "Resonetics is a recognized leader in micro manufacturing for the medical device and life sciences industries and I am excited to contribute to the company's continued success. I look forward to working closely with the executive team and our financial sponsors to capitalize on market opportunities, drive operational excellence, and ensure sustainable growth for Resonetics."
Former Resonetics CEO Tom Burns retired from his position on May 30, with Kelly taking over the role that day.
"We are thrilled to welcome Todd as Resonetics' next CFO," Kevin D. Kelly, president and CEO of Resonetics told the press. "His deep expertise in financial management, track record in building teams, and experience in the medical device industry make him an ideal fit for our organization. Todd will continue to elevate our financial operations and build scalable processes that enable our continued growth."
Before Resonetics, Trapp was executive VP and CFO for cardiovascular medtech company Abiomed. Prior to Abiomed, he was CFO of Watts Water Technologies. He also spent 23 years in senior financial and operational leadership roles at Honeywell.
"I am honored to join the Resonetics team as CFO," said Trapp. "Resonetics is a recognized leader in micro manufacturing for the medical device and life sciences industries and I am excited to contribute to the company's continued success. I look forward to working closely with the executive team and our financial sponsors to capitalize on market opportunities, drive operational excellence, and ensure sustainable growth for Resonetics."
Former Resonetics CEO Tom Burns retired from his position on May 30, with Kelly taking over the role that day.